Ramulus Mori (Sangzhi) alkaloids enhance pancreatic β-Cell maturation and function by targeting the CD81/endoplasmic

Nan Wu1, Wenjing Zhang1, Sunyue He1

  • 1Department of Endocrinology and Metabolism, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Abstract

Insights

Ramulus Mori Alkaloids (SZ-A) improve glucose metabolism in type 2 diabetes by promoting beta-cell maturation. SZ-A suppresses CD81, reducing ER stress and enhancing insulin secretion, offering a new therapeutic target.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • Beta-cell dysfunction, characterized by dedifferentiation and impaired maturation, is central to type 2 diabetes mellitus (T2DM).
  • Current therapeutic strategies targeting beta-cell function in T2DM are limited.

Purpose of the Study:

  • To investigate the protective effects of Ramulus Mori (Sangzhi) Alkaloids (SZ-A) on beta-cell function and maturation in a T2DM model.
  • To elucidate the underlying molecular mechanisms, focusing on the role of CD81 and endoplasmic reticulum (ER) stress.

Main Methods:

  • Induced T2DM in mice using high-fat diet and streptozotocin, followed by SZ-A treatment.
  • Utilized single-cell RNA sequencing (scRNA-seq) to profile beta-cell subpopulations and identify CD81 as a marker of immaturity.
  • Investigated CD81's role in SZ-A-mediated maturation using overexpression/knockdown models and assessed ER stress via Western blotting.

Main Results:

  • SZ-A treatment dose-dependently improved glucose metabolism in T2DM mice.
  • ScRNA-seq identified increased CD81 expression in immature beta-cells in T2DM, a state reversed by SZ-A.
  • CD81 overexpression diminished SZ-A's metabolic benefits; SZ-A alleviated CD81-mediated ER stress, partly via components DNJ and FAG, promoting insulin secretion.

Conclusions:

  • SZ-A promotes beta-cell maturation and function by suppressing CD81-mediated ER stress.
  • These findings highlight a novel therapeutic mechanism for SZ-A in T2DM.
  • CD81 emerges as a potential therapeutic target for T2DM intervention.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
529
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
418
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K